Cytokinetics Newsroom

Cytokinetics Is Maintained at Outperform by RBC Capital

Dow Jones13:12 ET

Cytokinetics Price Target Cut to $80.00/Share From $86.00 by Citigroup

Dow JonesMay 7 11:58 ET

Cytokinetics Analyst Ratings

BenzingaMay 7 11:47 ET

RBC Trims Price Target on Cytokinetics to $80 From $82, Keeps Outperform, Speculative Risk

MT NewswiresMay 7 07:55 ET

BofA Securities Maintains Cytokinetics(CYTK.US) With Hold Rating, Cuts Target Price to $45

Moomoo NewsMay 7 07:31 ET

Citi Maintains Cytokinetics(CYTK.US) With Buy Rating, Cuts Target Price to $80

Moomoo NewsMay 7 07:31 ET

H.C. Wainwright Maintains Cytokinetics(CYTK.US) With Buy Rating, Maintains Target Price $120

Moomoo NewsMay 7 07:31 ET

Cytokinetics: Hold Rating Amid FDA Delays and Commercial Uncertainties

TipRanksMay 7 05:44 ET

Strategic Opportunity and Management Confidence Underpin Buy Rating for Cytokinetics Despite FDA Delay

TipRanksMay 5 05:19 ET

Evercore ISI Remains a Buy on Cytokinetics (CYTK)

TipRanksMay 5 05:07 ET

Truist Financial Maintains Cytokinetics(CYTK.US) With Buy Rating

Moomoo NewsMay 3 01:31 ET

Stifel Maintains Cytokinetics(CYTK.US) With Buy Rating, Maintains Target Price $87

Moomoo NewsMay 3 01:31 ET

JMP Securities Maintains Cytokinetics(CYTK.US) With Buy Rating, Maintains Target Price $78

Moomoo NewsMay 3 01:31 ET

Cytokinetics Is Maintained at Neutral by UBS

Dow JonesMay 2 19:05 ET

UBS Maintains Neutral on Cytokinetics, Lowers Price Target to $41

BenzingaMay 2 18:55 ET

Cytokinetics Analyst Ratings

BenzingaMay 2 08:26 ET

BofA Securities Maintains Cytokinetics(CYTK.US) With Hold Rating, Cuts Target Price to $50

Moomoo NewsMay 2 07:31 ET

Needham Maintains Cytokinetics(CYTK.US) With Buy Rating, Maintains Target Price $72

Moomoo NewsMay 2 07:31 ET

H.C. Wainwright Maintains Cytokinetics(CYTK.US) With Buy Rating, Maintains Target Price $120

Moomoo NewsMay 2 07:31 ET

J.P. Morgan Maintains Cytokinetics(CYTK.US) With Buy Rating, Announces Target Price $71

Moomoo NewsApr 29 03:31 ET